免疫疗法
免疫系统
肿瘤微环境
生物
T细胞
细胞毒性T细胞
免疫学
表观遗传学
骨髓
癌症研究
祖细胞
细胞
干细胞
体外
细胞生物学
遗传学
生物化学
基因
作者
Juyeun Lee,Michael Nicosia,Daniel J. Silver,Cathy W. Y. Li,Defne Bayık,Dionysios C. Watson,Adam Lauko,Sadie Johnson,Mary McGraw,Matthew M. Grabowski,Danielle D. Kish,Amar Desai,Wendy A. Goodman,Scott J. Cameron,Hideo Okada,Anna Valujskikh,Robert L. Fairchild,Manmeet S. Ahluwalia,Justin D. Lathia
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2022-08-18
被引量:5
标识
DOI:10.1101/2022.08.17.503211
摘要
Abstract Sex differences in glioblastoma (GBM) incidence and outcome are well recognized, and emerging evidence suggests that these extend to genetic/epigenetic and cellular differences, including immune responses. However, the mechanisms driving immunological sex differences are not fully understood. Using GBM models, we demonstrate that T cells play a critical role in driving GBM sex differences. Male mice exhibited accelerated tumor growth, with decreased T cell infiltration and increased T cell exhaustion. Furthermore, a higher frequency of progenitor exhausted T cells was found in males, with improved responsiveness to anti-PD1 treatment. Bone marrow chimera and adoptive transfer models indicated that T cell-mediated tumor control was predominantly regulated in a cell-intrinsic manner, which was further corroborated by in vitro exhaustion assays. Moreover, increased T cell exhaustion was observed in male GBM patients. These findings demonstrate sex-specific pre-determined behavior of T cells is critical in inducing sex differences in GBM progression and immunotherapy response. Statement of significance Immunotherapies in GBM patients have been unsuccessful due to a variety of factors including the highly immunosuppressive tumor microenvironment in GBM. This study demonstrates that sex-specific T cell behaviors are predominantly intrinsically regulated, further suggesting sex-specific approaches can be leveraged to potentially improve therapeutic efficacy of immunotherapy in GBM.
科研通智能强力驱动
Strongly Powered by AbleSci AI